BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25464020)

  • 1. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
    Huan Y; Jiang Q; Liu JL; Shen ZF
    J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
    Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
    J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
    Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
    Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.
    Wang A; Dorso C; Kopcho L; Locke G; Langish R; Harstad E; Shipkova P; Marcinkeviciene J; Hamann L; Kirby MS
    BMC Pharmacol; 2012 Apr; 12():2. PubMed ID: 22475049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
    Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
    Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
    Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
    Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
    Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
    J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
    Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
    Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
    ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
    Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
    Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
    Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
    Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.
    Ross B; Krapp S; Augustin M; Kierfersauer R; Arciniega M; Geiss-Friedlander R; Huber R
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1437-E1445. PubMed ID: 29382749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited.
    Burkey BF; Hoffmann PK; Hassiepen U; Trappe J; Juedes M; Foley JE
    Diabetes Obes Metab; 2008 Nov; 10(11):1057-61. PubMed ID: 18422675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.
    Qi SY; Riviere PJ; Trojnar J; Junien JL; Akinsanya KO
    Biochem J; 2003 Jul; 373(Pt 1):179-89. PubMed ID: 12662155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Zhang H; Chen Y; Keane FM; Gorrell MD
    Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
    Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
    Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins.
    Liu J; Huan Y; Li C; Liu M; Shen Z
    Acta Pharm Sin B; 2014 Apr; 4(2):135-40. PubMed ID: 26579375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.